Stock ROVI LABORATORIOS FARMACEUTICOS ROVI, S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Equities

ROVI

ES0157261019

Real-time Estimate Tradegate
Other stock markets
 04:18:48 01/07/2024 pm IST 		5-day change 1st Jan Change
85.18 EUR +1.22% Intraday chart for Laboratorios Farmaceuticos Rovi, S.A. -2.04% +38.63%
26/06 Rovi receives non-binding offers for manufacturing business RE
08/05 Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Laboratorios Farmaceuticos Rovi S A : ROVI forecasts potential Risperidone ISM® sales of between 200 and 300 million euros globally in upcoming years
PU
Laboratorios Farmaceuticos Rovi S A : ROVI completes its new Escúzar plant by including a sodium heparin production facility
PU
Laboratorios Farmaceuticos Rovi S A : First three months 2024 results press release
PU
Laboratorios Farmaceuticos Rovi S A : ROVI announces agreement to manufacture pre-filled syringes
PU
Laboratorios Farmaceuticos Rovi S A : ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
PU
Laboratorios Farmaceuticos Rovi S A : First nine months 2023 results press release
PU
Laboratorios Farmaceuticos Rovi S A : ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
PU
Laboratorios Farmaceuticos Rovi S A : First half 2023 results press release
PU
Laboratorios Farmaceuticos Rovi S A : First quarter 2023 results press release
PU
Laboratorios Farmaceuticos Rovi S A : ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
PU
Laboratorios Farmaceuticos Rovi S A : ROVI plants a forest with 2,000 trees in the Madrid Sierra
PU
Laboratorios Farmaceuticos Rovi S A : BioSim strengthens its national representation with the incorporation of ROVI Pharmaceutical Laboratories
PU
Laboratorios Farmaceuticos Rovi S A : Full Year 2022 Results Press Release
PU
Laboratorios Farmaceuticos Rovi S A : ROVI informs on the evaluation process to obtain marketing authorisation for Risvan®
PU
Laboratorios Farmaceuticos Rovi S A : ROVI launches an initiative to develop solutions that improve sustained-release injectable drug delivery technologies
PU
Laboratorios Farmaceuticos Rovi S A : First nine months 2022 results press release
PU
Laboratorios Farmaceuticos Rovi S A : The President of the Andalusian Government, Juan Manel Moreno, visits the new Rovi plant in Escúzar (Granada)
PU
Laboratorios Farmaceuticos Rovi S A : ROVI tops the Sustainalytics sustainability ranking for the pharmaceutical subindustry worldwide
PU
Laboratorios Farmaceuticos Rovi S A : First half 2022 results press release
PU
Laboratorios Farmaceuticos Rovi S A : ROVI receives the positive opinion of the CHMP on Okedi® as a treatment for schizophrenia
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ROVI Stock
  4. ROVI Stock
  5. News Laboratorios Farmaceuticos Rovi, S.A.
  6. Press Releases